Which receptor superfamily produces the fastest response, on the order of milliseconds?
Choose an answer, then check it.
Clinical Pharmacology · Pharmacodynamics
Receptors
On this page 6 sections
In 30 seconds
A receptor is a protein that a drug or the body's own chemical messenger binds to in order to trigger a biological effect. Receptors give drugs their specificity — a drug only works where its matching receptor exists — and the receptor type a drug binds determines how fast and how long its effect lasts. Nearly every drug works through one of four receptor superfamilies. Understanding receptors explains why drugs work, why they cause side effects, and why doses sometimes need to change over time.
The college version
A receptor is a specialized protein, usually on or in a cell, that recognizes a specific chemical (a ligand) and changes shape or activity when that ligand binds. Natural ligands include neurotransmitters like acetylcholine and hormones like insulin. Drugs act as synthetic ligands that mimic or block these natural molecules.
Binding and Specificity
Binding depends on molecular fit, like a key fitting a lock: shape, charge, and size must complement the receptor's binding site. This fit determines affinity, the strength of attraction between drug and receptor. High-affinity drugs bind tightly and act at low concentrations. Specificity means a receptor responds to a narrow range of similar molecules, which is why a beta-blocker affects beta-adrenergic receptors but not opioid receptors. Whether binding activates (agonism) or blocks (antagonism) a receptor, and how strongly, is covered in the sibling topics on agonists/antagonists and potency/efficacy.
The Four Major Receptor Superfamilies
- Ligand-gated ion channels (ionotropic): The receptor is itself a channel. Ligand binding opens it, letting ions (Na+, K+, Ca2+, Cl-) cross the membrane within milliseconds. Example: the nicotinic acetylcholine receptor at the neuromuscular junction, which opens on binding and triggers muscle depolarization.
- G-protein-coupled receptors (GPCRs): These span the membrane seven times; ligand binding activates an intracellular G-protein, which triggers a second-messenger cascade. Effects take seconds and last longer. Example: beta-adrenergic receptors, which raise intracellular cyclic AMP (cAMP), increasing heart rate and contractility.
- Enzyme-linked receptors: These have an extracellular binding domain and an intracellular enzymatic domain, usually a tyrosine kinase. Binding causes the receptor to dimerize and phosphorylate downstream proteins, regulating growth and metabolism. Example: the insulin receptor, whose activation promotes glucose uptake over minutes to hours.
- Intracellular (nuclear) receptors: These sit in the cytoplasm or nucleus; their ligands must be lipid-soluble enough to cross the cell membrane. The receptor-ligand complex enters the nucleus and alters gene transcription. Example: corticosteroids binding glucocorticoid receptors to reduce inflammatory protein synthesis. Because new proteins must be made, effects take hours to days but last longest.
Signal Transduction and Second Messengers
Signal transduction converts an extracellular signal into an intracellular response. For ion channels, the signal is simply ion flow. For GPCRs, a second messenger — cAMP, calcium, or IP3 — relays and amplifies the signal to downstream enzymes. One bound receptor can activate many G-proteins, producing a large cellular response from a small amount of drug.
Spare Receptors
In many tissues, a maximal response occurs even when only a fraction of receptors are occupied; the rest are "spare receptors." Their existence explains why low drug concentrations can still produce strong effects, and it shifts the relationship between occupancy and response.
Receptor Regulation
Receptor number and sensitivity change with chronic stimulation. Downregulation — fewer or less sensitive receptors after prolonged agonist exposure — underlies drug tolerance, requiring higher doses over time. Upregulation — more or more-sensitive receptors after prolonged blockade — is part of why abruptly stopping drugs like beta-blockers can cause a dangerous rebound effect. These changes are central to tolerance and withdrawal, covered in that sibling topic.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine every cell has tiny mailboxes called receptors. Chemical messengers, or medicines, are like letters shaped a special way, and each mailbox only accepts letters shaped exactly right for it — that's why a heart medicine doesn't accidentally open a mailbox in your stomach.
There are four kinds of mailboxes. Some are like a door that swings open the instant the right letter arrives, letting things rush in immediately. Some are like an intercom button: the letter presses it, sending a message deeper inside through relay runners (the "second messengers"). Some are like a switch that turns on a tiny factory inside the cell. And some letters are small enough to slip through the front door and go straight to the control room (the nucleus) to change the house's blueprints.
If a mailbox gets the same letter over and over for weeks, the house may remove some mailboxes — that's downregulation, part of why bigger doses are sometimes needed over time. If letters stop coming, the house may build extra mailboxes back — that's upregulation.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient on a high-dose opioid for several weeks now needs progressively larger doses for the same pain relief. What receptor-level change likely explains this, and what is it called?
Show answer
Likely answer — downregulation of opioid receptors.
With opioid receptors constantly flooded by the drug, the cell removes or desensitizes some mailboxes so it isn't overwhelmed, so the same dose now produces less effect — a bigger dose is needed for the same relief.
A patient who stops a long-term beta-blocker abruptly develops a dangerously fast heart rate days later. Using receptor regulation, explain why.
Show answer
Likely answer — upregulation of beta receptors during chronic blockade, unmasked on withdrawal.
While on the beta-blocker, the heart's cells built extra beta-receptor mailboxes because the blocker kept usual mail from getting through. Stopping the drug suddenly frees all those extra mailboxes to receive the body's adrenaline-type signals at once, causing a rebound speeding-up of the heart.
Quick check
3 questions here. Answers stay hidden until you check.
A second messenger such as cyclic AMP is most directly associated with which receptor type?
Choose an answer, then check it.
Why do drugs acting on nuclear receptors, such as corticosteroids, typically take hours to days for full effect?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.